PARADIONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Paradione, and what generic alternatives are available?
Paradione is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in PARADIONE is paramethadione. Additional details are available on the paramethadione profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PARADIONE?
- What are the global sales for PARADIONE?
- What is Average Wholesale Price for PARADIONE?
Summary for PARADIONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | PARADIONE at DailyMed |
US Patents and Regulatory Information for PARADIONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | PARADIONE | paramethadione | CAPSULE;ORAL | 006800-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | PARADIONE | paramethadione | CAPSULE;ORAL | 006800-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | PARADIONE | paramethadione | SOLUTION;ORAL | 006800-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

